Discovery & Development

Despite clinical failures in the 1990s, pharma is (cautiously) ready to try again with oral peptide formulations.

More quality control testing is needed to ensure that antibiotics don't become targets for fraudsters.

Do Brazilian wasps hold the promise of a new anticancer therapy? The answer is in the sting

Drug makers and regulators are taking steps towards transparency, but is it enough?

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.

Prescription drug abuse has already reached epidemic proportions in the US – and other countries look set to follow the dangerous trend.

The true path to success as an entrepreneur is the ability to spot high impact problems – and to be fearless in the pursuit of great solutions.

Most pharma companies want to become more patient focused. But how? You could start by simply listening more carefully.

The feel of a topical formulation can make a big difference to compliance.

In this article we look at the steps involved in moving from a drug substance to a successful oral solid dosage (OSD) form, and at the analytical technologies that can be helpful.